Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced positive topline results from two ...

A new study published in the journal of BMC Endocrine Disorders showed that a high-quality carbohydrate diet with increased ...

The following is a summary of “Association between the triglyceride-glucose index and liver fibrosis in adults with ...

Among the general US population, simple and affordable non-invasive liver fibrosis scoring systems may be able to identify individuals at risk for HF.

Patients with indeterminate chronic hepatitis B (CHB) phase are at risk of progressing to advanced liver disease and hepatocellular carcinoma (HCC), according to study results published in the Journal ...

The liver, serving as the body's natural filtration system, faces significant challenges from alcohol consumption. As this ...

The liver can regenerate itself, but there are factors that make self-repair impossible. Find out what they are here.

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...

In a series of studies at McMaster, Dr. Schertzer’s research group demonstrated that treatment with QBECO SSI resulted in a marked reduction in liver fat, inflammation, and fibrosis in fatty liver ...

Discover how a Mediterranean diet, rich in whole grains, vegetables, fruits, nuts, and olive oil, is proven to improve liver health by reducing inflammation and fat accumulation.

Although metabolic dysfunction-associated steatotic liver disease (MASLD) has been proposed to replace the diagnosis of non-alcoholic fatty liver disease (NAFLD) with new diagnostic criteria since ...